Signals Report | Millennium Health | Drug Use Trends

Signals Report™

Millennium Health is committed to reporting on emerging drug use trends. Processing over a million specimens each year allows us to provide real-time analytics through our proprietary database of urine drug results. Our annual Millennium Health Signals Report identifies national, regional, and state drug use trends. Through our collaboration with clinicians, policy makers, and public health agencies, these innovative reports help improve the efficient use of available resources and positively impact the lives of patients, their families, and communities.

View Our Signals Reports Below

VOLUME 6

The “Fourth Wave” – The Rise of Stimulants and the Evolution of Polysubstance Use in America’s Fentanyl Crisis

The 6^th volume of our Signals Report centers on current drug use trends during the “Fourth Wave” of America’s overdose epidemic, in which stimulants are increasingly co-involved in fentanyl overdose deaths. We analyzed urine drug test results from more than 4 million patients across the 11 years since fentanyl first emerged as a major driver of overdose in the U.S. to illustrate the changing nature of polysubstance use among people who use fentanyl.

Download the Report

VOLUME 5.1

Zeroing in on Xylazine: The First 100 Days After U.S. Emerging Threat Designation

In this report, we evaluated the prevalence of xylazine across the U.S. among those who also used fentanyl and provide insights into xylazine-associated polysubstance use in the 100 days following the national emerging threat designation.

Download the Report

VOLUME 5

Fentanyl in Focus: Perspectives on Polysubstance Use in 2022

The 5^th volume of our Signals Report analyzed urine drug test results from more than 4.5 million specimens collected between 2015-2022 from all 50 states to bring Fentanyl in Focus and explore polysubstance use from several vantage points.

Download the Report

VOLUME 4

Keeping Current Drug Use Trends on Your RADAR^®

In this report, we analyzed results from 2 million unique patient urine specimens collected in health care specialties through December 2021. It highlights substantial changes in illicit drug use trends and provides findings regarding drugs known to contribute to drug overdose deaths.

Download the Report

VOLUME 3

The COVID-19 Connection: Tracking 2020 Trends in Drug Use

In this report, we analyzed our proprietary database of definitive urine drug test results to identify national, regional, and state trends in positivity rates for select drugs through December 2020, including an examination of drug use trends after the COVID-19 pandemic was declared a national emergency.

Download the Report

VOLUME 2.1

COVID-19 Special Edition: Significant Changes in Drug Use During the Pandemic

In this report, we evaluated the definitive urine drug testing positivity rates of non-prescribed fentanyl, cocaine, heroin and methamphetamine in the periods before and after COVID-19 was declared a national emergency.

Download the Report

VOLUME 2

Millennium Health Signals Report: National Drug Use Trends

In this report, we analyzed our proprietary database of definitive urine drug test results from January 2015 through November 2019 to identify national, regional, and state trends in positivity rates for select drugs. Sections include an evaluation of non-prescribed fentanyl, methamphetamine, heroin, cocaine, and kratom, as well as co-positivity between fentanyl and other illicit substances.

Download the Report

VOLUME 1

Millennium Health Signals Report™: National Drug Use Trends

In our first report, we analyzed our proprietary database of definitive urine drug test results from January 2013 through May 2018 to answer some of the most pressing questions associated with drug use trends. Sections include an evaluation of non-prescribed fentanyl co-identified with heroin, an in-depth look at gabapentinoids, and the frequency of drug detection among patients prescribed buprenorphine/naloxone.

Download the Report

Signals Report™

View Our Signals Reports Below

VOLUME 6

The “Fourth Wave” – The Rise of Stimulants and the Evolution of Polysubstance Use in America’s Fentanyl Crisis

VOLUME 5.1

Zeroing in on Xylazine: The First 100 Days After U.S. Emerging Threat Designation

VOLUME 5

Fentanyl in Focus: Perspectives on Polysubstance Use in 2022

VOLUME 4

Keeping Current Drug Use Trends on Your RADAR®

VOLUME 3

The COVID-19 Connection: Tracking 2020 Trends in Drug Use

VOLUME 2.1

COVID-19 Special Edition: Significant Changes in Drug Use During the Pandemic

VOLUME 2

Millennium Health Signals Report: National Drug Use Trends

VOLUME 1

Millennium Health Signals Report™: National Drug Use Trends

Contact Us

Keeping Current Drug Use Trends on Your RADAR^®